VERCYTE Drug Patent Profile
✉ Email this page to a colleague
When do Vercyte patents expire, and what generic alternatives are available?
Vercyte is a drug marketed by Abbott and is included in one NDA.
The generic ingredient in VERCYTE is pipobroman. Additional details are available on the pipobroman profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VERCYTE?
- What are the global sales for VERCYTE?
- What is Average Wholesale Price for VERCYTE?
Summary for VERCYTE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 68 |
| Patent Applications: | 4,515 |
| DailyMed Link: | VERCYTE at DailyMed |
US Patents and Regulatory Information for VERCYTE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbott | VERCYTE | pipobroman | TABLET;ORAL | 016245-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbott | VERCYTE | pipobroman | TABLET;ORAL | 016245-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
